Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beijing Succeeder TechnologySHSE:688338 +1.58%88 PS Ratio is 10.58 as of Jul. 27, 2026, which is 16% below its 10-year median of 12.59. GuruFocus rates SHSE:688338 with a GF Score™ of 88/100 and a GF Value™ of ¥30.92 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 804 Medical Devices & Instruments companies, Beijing Succeeder Technology ranks worse than 85.45% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Beijing Succeeder Technology's share price is ¥25.78.
Beijing Succeeder Technology's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ¥2.44. Hence, Beijing Succeeder Technology's PS Ratio for today is 10.58.
Good Sign:
Beijing Succeeder Technology Inc stock PS Ratio (=10.41) is close to 1-year low of 9.59.
The historical rank and industry rank for Beijing Succeeder Technology's PS Ratio or its related term are showing as below:
SHSE:688338'
s PS Ratio Range Over the Past 10 Years
Min: 7.3 Med: 12.59 Max: 41.77
Current: 10.57
During the past 10 years, Beijing Succeeder Technology's highest PS Ratio was 41.77. The lowest was 7.30. And the median was 12.59.
SHSE:688338's PS Ratio is ranked worse than 85.45% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 2.86
vs SHSE:688338: 10.57
During the past 10 years, Beijing Succeeder Technology's highest 3-Year average Revenue per Share Growth Rate was 18.60% per year. The lowest was -10.00% per year. And the median was 4.60% per year.
Back to Basics: PS Ratio
Beijing Succeeder Technology (SHSE:688338) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Beijing Succeeder Technology PS Ratio Related Terms
Beijing Succeeder Technology PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Beijing Succeeder Technology's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Succeeder Technology PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Beijing Succeeder Technology's PS Ratio distribution charts can be found below:
* The bar in red indicates where Beijing Succeeder Technology's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Beijing Succeeder Technology's Share Price of today is ¥25.78. Beijing Succeeder Technology's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.44.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Beijing Succeeder Technology (SHSE:688338) has a PS Ratio of 10.58 as of Jul. 27, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Beijing Succeeder Technology and its competitors. This is 16% below median its historical median of 12.59. Over the past decade, Beijing Succeeder Technology's PS Ratio has ranged from 7.30 to 41.77. According to the industry distribution chart, Beijing Succeeder Technology ranks #687 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 85.4%.
Is Beijing Succeeder Technology's PS Ratio too high?
Beijing Succeeder Technology's current PS Ratio of 10.58 is 16% below median its 10-year median of 12.59. Over the past 10 years, this metric has ranged from a low of 7.30 to a high of 41.77. The Medical Devices & Instruments industry median PS Ratio is 2.86. Beijing Succeeder Technology's value of 10.58 is 269.9% above this industry median. Based on the distribution chart, Beijing Succeeder Technology ranks #687 out of 804 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Beijing Succeeder Technology has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Succeeder Technology's PS Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Beijing Succeeder Technology ranks #687 out of 804 companies for PS Ratio. This places Beijing Succeeder Technology in the lower half of its industry. The industry median PS Ratio is 2.86. Beijing Succeeder Technology's value of 10.58 is 269.9% above this benchmark. Historically, Beijing Succeeder Technology's own PS Ratio has ranged from 7.30 to 41.77 over the past decade. While the company's 10-year median is 12.59 vs. the industry median of 2.86, Beijing Succeeder Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.86, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Succeeder Technology's current PS Ratio of 10.58 is 269.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Beijing Succeeder Technology and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Succeeder Technology's current PS Ratio is 10.58, which is 16% below median its own 10-year median of 12.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Succeeder Technology stock overvalued right now?
Based on GuruFocus' analysis, Beijing Succeeder Technology (SHSE:688338) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥30.92, compared to a current price of ¥25.78 — trading 16.6% below its estimated fair value. The current PS Ratio is 10.58, which is 16% below median its 10-year median of 12.59 and 269.9% above the Medical Devices & Instruments industry median of 2.86. Beijing Succeeder Technology's overall GF Score™ is 88/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Beijing Succeeder Technology (SHSE:688338), the current PS Ratio is 10.58 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Succeeder Technology (SHSE:688338) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Succeeder Technology stock appears to be undervalued.
The current stock price of ¥25.78 is trading 16.6% below its estimated GF Value™ of ¥30.92.
GuruFocus considers Beijing Succeeder Technology to be Modestly Undervalued.
Key valuation signals for SHSE:688338:
PS Ratio: 10.58 (16% below median its 10-year median of 12.59)
GF Value™: ¥30.92 vs. price of ¥25.78 (16.6% below fair value)
Industry Position: 269.9% above the Medical Devices & Instruments median (#687 of 804)
No single metric tells the full story. See the SHSE:688338 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Succeeder Technology Inc is engaged in production and sales of detection instruments, reagents and consumables in the field of in vitro diagnosis of thrombosis and hemostasis. The company develops, manufactures and sells in-vitro diagnostic products including coagulation analyzers and reagents, blood rheology analyzers, ESR analyzers and platelet aggregation analyzers. Its product portfolio includes Fully Auto Coagulation Analyzer; Semi Auto Coagulation Analyzer; ESR Analyzer; Platelet Aggregation Analyzer; and Coagulation Reagents.
88GF Score
Get the complete analysis for SHSE:688338
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688338 has been successfully added to your 
